Platinum-based chemotherapy may improve outcomes for some metastatic pancreatic cance
Patients with metastatic pancreatic cancer who had germline or somatic mutations in DNA repair genes had better clinical outcomes after platinum-based chemotherapy, as compared with patients without these mutations.